Comparisons of average annual age-adjusted cancer incidence rates in Indian women of Alaska and New Mexico and U.S. White women, 1993-2002
| . | Age-adjusted rates (women), rate (n) . | . | AK:NM, OR (95% CI) . | U.S. White, rate . | AK:U.S., OR (95% CI) . | |
|---|---|---|---|---|---|---|
| . | Alaska Indian . | New Mexico Indian . | . | . | . | |
| All sites | 603.6 (638) | 222.4 (1,238) | 2.8* (2.5-3.0) | 462.2 | 1.5* (1.4-1.6) | |
| Oral cavity and pharynx | 13 (12.3) | 13 (2.1) | 5.1* (2.4-10.9) | 6.7 | 1.9* (1.1-3.3) | |
| Salivary gland | 4 (3.0) | 3 (0.3) | 1.0 | |||
| Nasopharynx | 2 (1.8) | 5 (1.0) | 0.3 | |||
| Gum and other oral cavity | 2 (2.4) | 0 | ||||
| Digestive | 135 (144.0) | 295 (60.1) | 72.6 | |||
| Esophagus | 4 (4.7) | 2 (0.5) | 1.9 | |||
| Stomach | 14 (12.9) | 56 (11.5) | 1.3 (0.7-2.4) | 5.1 | 3.0* (1.8-5.1) | |
| Colorectal | 83 (89.9) | 111 (21.0) | 4.0* (3.0-5.4) | 45.8 | 2.0* (1.6-2.5) | |
| Colon | 56 (61.5) | 83 (15.5) | 3.6* (2.6-5.1) | 34.4 | 1.9* (1.4-2.4) | |
| Rectum and Rectosigmoid junction | 27 (28.5) | 28 (5.6) | 5.2* (3.1-8.9) | 11.4 | 2.5* (1.7-3.7) | |
| Liver | 6 (7.1) | 20 (6.6) | 1.7 (0.7-4.2) | 2.1 | 3.0* (1.3-6.7) | |
| Gallbladder | 5 (5.2) | 31 (7.0) | 0.9 (0.3-2.3) | 1.6 | 3.6* (1.5-8.7) | |
| Other biliary | 1 (0.9) | 17 (3.7) | 1.2 | |||
| Pancreas | 13 (13.6) | 39 (8.1) | 1.8 (1.0-3.5) | 9.6 | 1.6 (0.9-2.7) | |
| Respiratory | 71 (76.2) | 45 (9.4) | 53.9 | |||
| Lung and bronchus | 68 (72.9) | 38 (7.9) | 10.0* (6.7-14.8) | 51.4 | 1.5* (1.2-1.9) | |
| Larynx | 1 (0.9) | 1 (0.2) | 1.5 | |||
| Bones and joints | 1 (0.4) | 4 (0.5) | 0.8 | |||
| Soft tissue | 4 (2.2) | 15 (2.1) | 2.4 | |||
| Melanoma of the skin | 6 (3.3) | 8 (1.0) | 3.5* (1.2-10.2) | 16.1 | 0.3* (0.1-0.6) | |
| Other nonepithelial skin | 2 (2.4) | 5 (0.8) | 1.5 | |||
| Breast | 253 (232.8) | 301 (51.6) | 4.5* (3.8-5.3) | 138.6 | 1.7* (1.5-2.0) | |
| Female genital | 67 (57.1) | 238 (40.0) | 54.0 | |||
| Cervix | 13 (8.6) | 60 (9.4) | 1.1 (0.6-2.0) | 9.2 | 1.0 (0.6-1.7) | |
| Corpus uteri/uterus, NOS | 23 (21.3) | 91 (14.8) | 1.3 (0.8-2.0) | 25.9 | 0.9 (0.6-1.3) | |
| Ovary | 16 (15.6) | 71 (13.0) | 1.2 (0.7-2.1) | 25.5 | 1.0 (0.6-1.6) | |
| Urinary | 20 (23.3) | 66 (12.3) | 18.3 | |||
| Urinary bladder | 4 (4.4) | 6 (1.3) | 9.9 | |||
| Kidney and renal pelvis | 15 (17.5) | 59 (10.8) | 1.4 (0.8-2.4) | 7.9 | 1.8* (1.1-3.1) | |
| Eye and orbit | 0 | 3 (0.6) | 0.8 | |||
| Brain and nervous system | 6 (3.0) | 16 (2.0) | 1.8 (0.7-4.6) | 5.9 | 0.7 (0.3-1.6) | |
| Endocrine | 21 (13.6) | 62 (8.7) | 10.9 | |||
| Thyroid | 21 (13.6) | 61 (8.6) | 1.7 (1.0-2.7) | 10.4 | 1.3 (0.9-2.0) | |
| Lymphoma | 10 (9.0) | 52 (9.7) | 19.0 | |||
| Hodgkin's disease | 3 (1.3) | 5 (0.6) | 2.6 | |||
| Non–Hodgkin's | 7 (7.7) | 47 (9.0) | 0.8 (0.4-1.8) | 16.4 | 0.4* (0.2-0.9) | |
| Multiple myeloma | 10 (9.4) | 22 (4.3) | 2.5* (1.2-5.3) | 4.2 | 2.6* (1.4-4.9) | |
| Leukemia | 12 (8.2) | 31 (4.3) | 1.9 (1.0-3.8) | 10.1 | 1.0 (0.6-1.7) | |
| III Defined and unspecified | 7 (6.5) | 62 (13.0) | 10.3 | |||
| . | Age-adjusted rates (women), rate (n) . | . | AK:NM, OR (95% CI) . | U.S. White, rate . | AK:U.S., OR (95% CI) . | |
|---|---|---|---|---|---|---|
| . | Alaska Indian . | New Mexico Indian . | . | . | . | |
| All sites | 603.6 (638) | 222.4 (1,238) | 2.8* (2.5-3.0) | 462.2 | 1.5* (1.4-1.6) | |
| Oral cavity and pharynx | 13 (12.3) | 13 (2.1) | 5.1* (2.4-10.9) | 6.7 | 1.9* (1.1-3.3) | |
| Salivary gland | 4 (3.0) | 3 (0.3) | 1.0 | |||
| Nasopharynx | 2 (1.8) | 5 (1.0) | 0.3 | |||
| Gum and other oral cavity | 2 (2.4) | 0 | ||||
| Digestive | 135 (144.0) | 295 (60.1) | 72.6 | |||
| Esophagus | 4 (4.7) | 2 (0.5) | 1.9 | |||
| Stomach | 14 (12.9) | 56 (11.5) | 1.3 (0.7-2.4) | 5.1 | 3.0* (1.8-5.1) | |
| Colorectal | 83 (89.9) | 111 (21.0) | 4.0* (3.0-5.4) | 45.8 | 2.0* (1.6-2.5) | |
| Colon | 56 (61.5) | 83 (15.5) | 3.6* (2.6-5.1) | 34.4 | 1.9* (1.4-2.4) | |
| Rectum and Rectosigmoid junction | 27 (28.5) | 28 (5.6) | 5.2* (3.1-8.9) | 11.4 | 2.5* (1.7-3.7) | |
| Liver | 6 (7.1) | 20 (6.6) | 1.7 (0.7-4.2) | 2.1 | 3.0* (1.3-6.7) | |
| Gallbladder | 5 (5.2) | 31 (7.0) | 0.9 (0.3-2.3) | 1.6 | 3.6* (1.5-8.7) | |
| Other biliary | 1 (0.9) | 17 (3.7) | 1.2 | |||
| Pancreas | 13 (13.6) | 39 (8.1) | 1.8 (1.0-3.5) | 9.6 | 1.6 (0.9-2.7) | |
| Respiratory | 71 (76.2) | 45 (9.4) | 53.9 | |||
| Lung and bronchus | 68 (72.9) | 38 (7.9) | 10.0* (6.7-14.8) | 51.4 | 1.5* (1.2-1.9) | |
| Larynx | 1 (0.9) | 1 (0.2) | 1.5 | |||
| Bones and joints | 1 (0.4) | 4 (0.5) | 0.8 | |||
| Soft tissue | 4 (2.2) | 15 (2.1) | 2.4 | |||
| Melanoma of the skin | 6 (3.3) | 8 (1.0) | 3.5* (1.2-10.2) | 16.1 | 0.3* (0.1-0.6) | |
| Other nonepithelial skin | 2 (2.4) | 5 (0.8) | 1.5 | |||
| Breast | 253 (232.8) | 301 (51.6) | 4.5* (3.8-5.3) | 138.6 | 1.7* (1.5-2.0) | |
| Female genital | 67 (57.1) | 238 (40.0) | 54.0 | |||
| Cervix | 13 (8.6) | 60 (9.4) | 1.1 (0.6-2.0) | 9.2 | 1.0 (0.6-1.7) | |
| Corpus uteri/uterus, NOS | 23 (21.3) | 91 (14.8) | 1.3 (0.8-2.0) | 25.9 | 0.9 (0.6-1.3) | |
| Ovary | 16 (15.6) | 71 (13.0) | 1.2 (0.7-2.1) | 25.5 | 1.0 (0.6-1.6) | |
| Urinary | 20 (23.3) | 66 (12.3) | 18.3 | |||
| Urinary bladder | 4 (4.4) | 6 (1.3) | 9.9 | |||
| Kidney and renal pelvis | 15 (17.5) | 59 (10.8) | 1.4 (0.8-2.4) | 7.9 | 1.8* (1.1-3.1) | |
| Eye and orbit | 0 | 3 (0.6) | 0.8 | |||
| Brain and nervous system | 6 (3.0) | 16 (2.0) | 1.8 (0.7-4.6) | 5.9 | 0.7 (0.3-1.6) | |
| Endocrine | 21 (13.6) | 62 (8.7) | 10.9 | |||
| Thyroid | 21 (13.6) | 61 (8.6) | 1.7 (1.0-2.7) | 10.4 | 1.3 (0.9-2.0) | |
| Lymphoma | 10 (9.0) | 52 (9.7) | 19.0 | |||
| Hodgkin's disease | 3 (1.3) | 5 (0.6) | 2.6 | |||
| Non–Hodgkin's | 7 (7.7) | 47 (9.0) | 0.8 (0.4-1.8) | 16.4 | 0.4* (0.2-0.9) | |
| Multiple myeloma | 10 (9.4) | 22 (4.3) | 2.5* (1.2-5.3) | 4.2 | 2.6* (1.4-4.9) | |
| Leukemia | 12 (8.2) | 31 (4.3) | 1.9 (1.0-3.8) | 10.1 | 1.0 (0.6-1.7) | |
| III Defined and unspecified | 7 (6.5) | 62 (13.0) | 10.3 | |||
NOTE: Rates are age adjusted to U.S. 2000 standard population. Source of data for New Mexico American Indian and U.S. Whites: SEER Program, Cancer Statistics Branch, National Cancer Institute, 2004. Alaska Indian data are from the Alaska Native Tumor Registry, Alaska Native Tribal Health Consortium, Anchorage, AK.
Abbreviations: AK:NM, Alaska:New Mexico; AK:US, Alaska:United States; OR (95% CI), odds ratio (95% confidence interval).
Significant OR at P < 0.05.